RGX-104 (hydrochloride)
RGX-104 hydrochloride is a small-molecule LXR agonist that modulates innate immunity via transcriptional activation of the ApoE gene.
Product Specifications
CAS Number
[610318-03-1]
Product Name Alternative
Abequolixron (hydrochloride)
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
LXR
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/RGX-104.html
Purity
99.88
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(O)CC1=CC=CC(OCC[C@H](N(CC2=CC=CC(C(F)(F)F)=C2Cl)CC(C3=CC=CC=C3)C4=CC=CC=C4)C)=C1.Cl
Molecular Formula
C34H34Cl2F3NO3
Molecular Weight
632.54
Precautions
H302, H315, H319, H335
References & Citations
[1]Tavazoie MF, et al. LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer. Cell. 2018 Feb 8;172 (4) :825-840.e18.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Available Sizes
Explore Other Products
Browse additional items from our catalog
RAG1AP1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
![Mouse Monoclonal Cytokeratin 15 Antibody (KRT15/2959) [FITC]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
Mouse Monoclonal Cytokeratin 15 Antibody (KRT15/2959) [FITC]
SCA20 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)